Skip to content

A Professional Development Programme (ProDeveloP) for Newly Graduated Nurses

Implementing a Professional Development Programme (ProDeveloP): an Introduction for Newly Graduated Nurses

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06742047
Enrollment
101
Registered
2024-12-19
Start date
2022-11-27
Completion date
2025-10-01
Last updated
2026-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Development, Nurse Role, Professional Fulfillment, Professional Identity Formation, Professional Quality of Life, Support Program

Keywords

Introduction programme, Newly graduated nurses, Professional development, Role clarity, Task mastery, Stress, Recovery, Reflection, Social acceptance, Transition support, Dialogue group, Registered nurse, Focus group, Intervention, Interview, Intensive measures

Brief summary

This clinical study aims to implement and evaluate a professional development programme (ProDeveloP) designed to facilitate the transition of newly graduated nurses (NGNs) into their new roles. NGNs face several challenges in the work environment and in developing their professional competencies. The aim is to support NGNs in a county hospital in central Sweden to facilitate their professional development. Data will be collected during the NGNs' first year through measures at week week 13 (for both arms) and quarterly (intervention grpoup). This will be combined with individual interviews and focus groups with NGNs, dialogue facilitators and managers.

Detailed description

The primary outcomes will be role clarity, task mastery, social acceptance, recovery and stress. The researchers will compare the results of the primary outcomes with those of a control group measure. Secondary outcomes will be experience of the intervention, transition support, job satisfaction and intention to leave. Informed consent was signed prior to participation in the study. The ethical application has been approved by the Ethics Authority IS, diary number 2022-05682-0.

Interventions

BEHAVIORALProfessional development programme

The professional development programme include dialogue groups facilitated by registered nurses (RN) who are expert and experienced supervisors that received a three day training before conducting the groups. Then including education days with joint lectures and simulations with experts in the field with experience. The programme provides NGNs with regular opportunities for reflection for learning from experiences of care to enhance personal and professional growth.

Sponsors

Mälardalen University
Lead SponsorOTHER
Region Västmanland
CollaboratorOTHER
AFA Insurance
CollaboratorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Intervention model description

Two cohorts of NGNs received the ProDevelop intervention in 2023 and 2024. A control group in 2022 did not receive the intervention but the previous introduction programme.

Eligibility

Sex/Gender
ALL
Age
20 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Registered nurses in Sweden employed as Newly Graduated Nurses (NGNs) in a county in central Sweden participating in the ProDeveloP, the intervention group. * Registered nurses in Sweden employed as Newly Graduated Nurses (NGNs) in a county in central Sweden, NGNs participating in the introduction programme prior to the study, not participating in the ProDeveloP, the control group. * Experienced registered nurses as facilitators for the dialogue groups for the NGNs in the intervention. * Managers at the county hospital for the NGNs participating in the intervention.

Exclusion criteria

• Managers without NGNs participated in the intervention.

Design outcomes

Primary

MeasureTime frameDescription
Role ClarityThe measurement was collected at one time point at thirteen weeks of participation in the ProDeveloP for the intervention group or in the prior introduction programme for the control group.Role clarity, the professional development process in terms of gaining clarity about the responsibilities content and boundaries of the role, was measured with the Validated scale from the Questionnaire for Psychological and Social Factors at Work (QPS Nordic). A 5-point Likert scale was used with three items. During the last week, how did you feel about: 1. Having clearly defined goals? 2. You know what your responsibilities are? 3. You know exactly what is required of you at work? These items range from 'Very seldom or never (0)' to 'Very often or always' (4). The items were summed to between 0-12. Higher summed scores indicated better outcomes.
Task MasteryThe measurement was collected at one time point at thirteen weeks of participation in the ProDeveloP for the intervention group or in the prior introduction programme for the control group.Task mastery was measured with the validated scale from Swedish version of the Needs Satisfaction and Frustration Scale (NSFS). A 5-point Likert scale was used with two items. 1. During the last week, have you felt that you have been able to fulfil even the most demanding tasks? 2. During the last week, have you felt that you have been good at doing your job? These items range from 'Very seldom or never (0)' to 'Very often or always' (4). The items were summed to between 0-8. Higher summed scores indicated better outcomes.
Social AcceptanceThe measurement was collected at one time point at thirteen weeks of participation in the ProDeveloP for the intervention group or in the prior introduction programme for the control group.Social acceptance, of being integrated into the work group and belonging at work, was measured with the validated Needs Satisfaction and Frustration Scale (NSFS). A 5-point Likert scale was used with two items. During the last week: I have felt that the people I work with have really cared about me? I have felt included in the work group?A 5-point lickert scale was used. These items range from 'Very seldom or never (0)' to 'Very often or always' (4). The items were summed to between 0-8. Higher summed scores indicated better outcomes.
StressThe measurement was collected at one time point at thirteen weeks of participation in the ProDeveloP for the intervention group or in the prior introduction programme for the control group.Stress levels was measured with the validated Stress and Energy Questionnaire (SEQ). A 5-point Likert scale was used with three items. During the last week when you have been working, how often have you felt: 1. Tense? 2. Stressed? 3. Pressured? These items range from 'Very seldom or never (0)' to 'Very often or always' (4). The items were summed to between 0-12. Lower summed scores indicated better outcomes.

Secondary

MeasureTime frameDescription
Job SatiscationMeasured during months 4, 8 and 12 after enrollment of the intervention. No control group measurements are available for the secondary outcomes.Job satisfaction was measrued validated Job Satisfaction scale with 5-point lickert scale with three items. How often do you feel about your work in the following ways 1. I feel happy at work? 2. I feel satisfied with the work I have? 3. I feel satisfaction with my work? Range from 'Very seldom or never´(0) och 'Very often or often´ (4). Summed items to between 0-12. Higher scores better outcomes.
Intentions to LeaveMeasured during months 4, 8 and 12 after enrollment of the intervention. No control group measurements are available for the secondary outcomes.Intentions to leave the workplace or profession was measured by the validated Organizational Commitment on Job Turnover Intention scale. Please respond to the following statements about changing workplace: 1. I often think about leaving my current place of work? 2. As sson as possible I will leave my current workplace? 3. I am actively looking for a job outside my current workplace? Please comment on the following statements about changing profession: 1. I often think about changing profession? 2. I actively look for work outside this profession? 3. I would like to leave this profession as soon as possible? Using a 7-point Likert scale with a range of 'completely incorrrect´ (0) to'completely correct´ (6).
RecoveryMeasured during months 4, 8 and 12 after enrollment of the intervention. No control group measurements are available for the secondary outcomes.Recovery was measured by the validated Karolinska Sleep Questionnaireith 5-point Likert scale ranging from "not at all" to "very much". The Sleep quality of 3 items from the subjective meaning of good sleep from: 1\. Did you have trouble falling asleep last night? 2. How did you sleep last night? 3. Have you slept restlessly? 2 item of being able to let go of work thoughts 1. During the past week, have I had difficulty letting go of thoughts about work during my free time? 2. During the past week, have you been able to relax? 1 items engagement in leisure activities scale of using a 5-point Lickert scale ranging from "never" to "daily". 1\. During the past week, have you been able to do activities that give you energy?

Countries

Sweden

Contacts

PRINCIPAL_INVESTIGATORMargareta Asp, Professor

Mälardalens University

Participant flow

Recruitment details

Participants in the intervention ProDeveloP on 6 February and 9 September 2023, or in the prior introduction programme in 27 November 2022 were recruited in the hospital education centre (n = 101).

Pre-assignment details

The number of participants that Started were in total 101. 62 in the intervention group and 39 in the control group. No participant where excluded from the groups and if they did not participated in the study they could participate in the programmes.

Baseline characteristics

Characteristic
Age, Continuous32 years
STANDARD_DEVIATION 7.05
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
0 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
27 Participants
Number of weeks of work before programme5.37 number of weeks
STANDARD_DEVIATION 5.9
Parents born outside Sweden24 participants
Sex: Female, Male
Female
25 Participants
Sex: Female, Male
Male
6 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 620 / 39
other
Total, other adverse events
0 / 620 / 39
serious
Total, serious adverse events
0 / 620 / 39

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 19, 2026